Roche said on Friday that it has signed a development and distribution agreement with PathAI to work on artificial intelligence-based digital pathology applications.

Research has shown that an oxidation-antioxidant imbalance in the blood is an early indicator of Alzheimer's disease, rather than a consequence.

FDA clearance for a watch it says is capable of detecting atrial fibrillation through a medical-grade ECG and measuring blood oxygen levels from the wrist.

Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, announced today that it has signed a definitive agreement to acquire Bolder Surgical, a privately held, U.S.-based company that provides advanced energy vessel sealing surgical devices, for approximately $160 million.

Agilent Technologies Inc. today announced its Ki-67 IHC MIB-1 pharmDxis now FDA approved as an aid in identifying patients with early breast cancer at high risk of disease recurrence, for whom adjuvant treatment with Verzenio® (abemaciclib) in combination with endocrine therapy is being considered.

Many variants in the human genome have been linked to type 2 diabetes, but because most do not lie within genes that code for proteins, it¡¯s unclear how they might cause disease.

Thermo Fisher Scientific said on Wednesday that it has priced an offering of €5.25 billion ($6.06 billion) aggregate principal amount of four types of euro-denominated notes.

South Korean diagnostics firm Genematrix announced on Tuesday that its new human papillomavirus detection kit has received CE marking.

Monitoring changes in the viral genome is continuing to play a crucial role in shaping the response to the COVID-19 pandemic.

A trio of chemists at Indiana University Bloomington has created a new sensor to detect chemical changes in immune cells during the breakdown of pathogens.

Recently, the 2021 International Market Briefing & Financial Analyst Briefing held in conjunction with the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo ended successfully in Atlanta, USA.

The ability to detect a tumor earlier, when it is smaller, reduces the impact of surgery and treatment, improving the prognosis for many patients.

During the pandemic, it has become evident that people with cardiovascular disease and obesity are at much higher risk of developing very severe, even fatal COVID-19 disease. Researchers at Karolinska Institutet have identified some metabolic processes that SARS-CoV-2 uses to attack lung tissue.

A new study has used a state-of-the-art blood test to track damage to the brain in people who have sustained traumatic brain injury (TBI).

Early in the COVID-19 pandemic, individuals with Alzheimer's disease were identified as being at increased risk of developing severe COVID-19.